We are pleased to introduce the collection Model Organisms in Experimental Pharmacology and Drug Discovery.
Model organisms are non-human species that are used in the lab environment to help scientists understand biological processes. Model organisms represent an invaluable resource for fundamental and applied research, allowing prediction studies, modeling, and the identification of action mechanisms. This article collection will showcase studies of Model Organisms from bacteria, yeast, viruses, animals, and any others that have significance to the field of experimental pharmacology and drug discovery as a whole.
Classically used for biomedical studies, model organisms are progressively entering many disciplines within pharmacology. Drug development requires tests on model organisms before approval of new drugs can be tested on humans. This makes studies obtained using model organisms essential for progress within the field. We aim to acknowledge the use of model organisms and the research carried out to determine the best model organisms within the field. In response to the vast and dynamic progress of achievements in this field, this collection will also consider manuscripts introducing the use of newly established or emerging model organisms with accurate data supporting the conclusion.
This Research Topic welcomes original research, reviews, mini-reviews, perspectives manuscripts within, but not limited to, the following areas:
• Analysis to determine the most appropriate model organisms in research to determine new potential pharmaceuticals, their impact on target etc.
• Comparative studies of different organisms to study pharmacology and drug discovery.
• Organisms used in models for studying disease states, drug targets, and side effects.
• The use of model organisms in determining mechanisms of drug action and the assessment of interactions between drugs and targets.
Please note: Manuscripts submitted to the section must fall within the scope of the section. Please refer to section scope and authors guidelines.
We are pleased to introduce the collection Model Organisms in Experimental Pharmacology and Drug Discovery.
Model organisms are non-human species that are used in the lab environment to help scientists understand biological processes. Model organisms represent an invaluable resource for fundamental and applied research, allowing prediction studies, modeling, and the identification of action mechanisms. This article collection will showcase studies of Model Organisms from bacteria, yeast, viruses, animals, and any others that have significance to the field of experimental pharmacology and drug discovery as a whole.
Classically used for biomedical studies, model organisms are progressively entering many disciplines within pharmacology. Drug development requires tests on model organisms before approval of new drugs can be tested on humans. This makes studies obtained using model organisms essential for progress within the field. We aim to acknowledge the use of model organisms and the research carried out to determine the best model organisms within the field. In response to the vast and dynamic progress of achievements in this field, this collection will also consider manuscripts introducing the use of newly established or emerging model organisms with accurate data supporting the conclusion.
This Research Topic welcomes original research, reviews, mini-reviews, perspectives manuscripts within, but not limited to, the following areas:
• Analysis to determine the most appropriate model organisms in research to determine new potential pharmaceuticals, their impact on target etc.
• Comparative studies of different organisms to study pharmacology and drug discovery.
• Organisms used in models for studying disease states, drug targets, and side effects.
• The use of model organisms in determining mechanisms of drug action and the assessment of interactions between drugs and targets.
Please note: Manuscripts submitted to the section must fall within the scope of the section. Please refer to section scope and authors guidelines.
